From 2020 to 7-Figure Portfolio

A lot has happened since my last post in 2020. Between managing my business, guiding my children through their education, and renovating our home, blogging naturally took a back seat.

At one point, I even started a separate blog—myinvestmentsystem.blogspot.sg—to chart out a new methodology. Looking back, though, staying right here feels right. This platform captures the honest reality of my growth: evolving from pure small-cap investing toward a balanced strategy that pairs high-quality blue chips with selective small and mid-caps to generate stronger, more reliable cash flow.

Maintaining strong conviction in Singapore’s banking giants proved to be one of my best moves, yielding multi-bagger gains. Combined with multi-bagger returns from a few key small/mid-caps, these positions officially pushed my portfolio into 7-figure territory last year.

With a solid foundation now in place, I am excited to resume writing here. I will be sharing my complete portfolio holdings and exact asset allocations in my very next post.

Portfolio as per June 2020 (Late Post)

 

Portfolio as per 4 June 2020:

No.	Counters	No of Shares	Market Price per Share (SGD)	Total Value (SGD)	Allocation (%)
1	AIMS Apac Reit	15,500	$1.25	$19,375.00	3.89%
2	Ascendas-iTrust	13,000	$1.44	$18,720.00	3.76%
3	AEM	10,000	$3.13	$31,300.00	6.29%
4	Ascendas Reit	4,000	$3.16	$12,640.00	2.54%
5	Capitar China Trust	11,600	$1.34	$15,171.00	3.05%
6	CapitaMall Trust	6,200	$2.09	$12,958.00	2.60%
7	DBS	2,000	$21.99	$43,980.00	8.83%
8	Frasers Centrepoint Tr	7,000	$2.56	$17,920.00	3.60%
9	Frencken	12,000	$0.81	$9,720.00	1.95%
10	Frasers L&I Trust	17,500	$1.18	$20,650.00	4.15%
11	IREIT Global	16,500	$0.735	$12,127.00	2.44%
12	Lendlease	13,000	$0.715	$9,295.00	1.87%
13	Mapletree Com Trust	3,000	$2.08	$6,240.00	1.25%
14	Mapletree NAC Trust	30,000	$0.925	$27,750.00	5.58%
15	Mapletree Ind Trust	2,000	$2.65	$5,300.00	1.06%
16	Mapletree Log Trust	3,200	$1.94	$6,208.00	1.25%
17	Netlink	10,000	$1.02	$10,200.00	2.05%
18	OCBC	3,400	$0.93	$31,620.00	6.35%
19	Suntec Reit	5,000	$1.57	$7,850.00	1.58%
20	Sunningdale	40,000	$1.03	$41,200.00	8.28%
21	UOB	2,000	$21.63	$43,260.00	8.69%
22	Keppel Pac US Reit (US$)	10,000	US$0.71	$13,346.00	2.68%
23	Manulife Reit (US$)	3,000	US$0.82	$3,444.00	0.69%
24	Prime Reit (US$)	3,000	US$0.78	$3,276.00	0.66%
25	Akebia Therapeutics	300	US$12.08	$5,073.00	1.01%
26	Veeva Systems	230	US$214.90	$69,197.00	13.9%
27	Cash			$0.00
			TOTAL:	$497,820.00	100%

(1) Portfolio value YTD has increased from $468,620 to $497,820 (including capital injection) or to $471,820.00 (+0.68% against STI -16.75%).

(2) Capital injected in 2020: $26,000.

(3) Total Projected Dividend 2020: $22,000.00

Portfolio as per March 2020 (Late Post)

 

Portfolio as per 24 March 2020:

No.	Counters	No of Shares	Market Price per Share (SGD)	Total Value (SGD)
1	AIMS Apac REIT	15,500	$0.93	$15,500.00
2	AEM	5,000	$1.54	$7,700.00
3	Ascendas REIT	4,000	$2.29	$9,160.00
4	Comfort Delgro	7,000	$1.39	$9,730.00
5	Cache Log Trust	7,000	$0.36	$2,520.00
6	CRCT	8,600	$0.985	$8,471.00
7	CapitalMall Trust	4,200	$1.61	$6,762.00
8	DBS	1,700	$16.88	$28,696.00
9	Frasers L&I Trust	20,500	$0.665	$13,632.50
10	Innotek	30,000	$0.34	$10,200.00
11	IREIT Global	11,500	$0.415	$4,772.50
12	MNAC Trust	3,000	$0.695	$2,085.00
13	Mapletree Ind Trust	2,000	$1.91	$3,820.00
14	Mapletree Log Trust	3,200	$1.24	$3,968.00
15	Netlink Trust	10,000	$0.84	$8,400.00
16	OCBC	2,600	$7.81	$20,306.00
17	Singtel	3,000	$2.28	$6,840.00
18	SPH	3,000	$1.65	$4,950.00
19	Suntec REIT	5,000	$1.11	$5,550.00
20	Sunningdale	40,000	$0.75	$30,000.00
21	UOB	1,300	$17.57	$22,841.00
22	HSBC (Hongkong)	1,600	HK$44.20	$13,346.00
23	Keppel Pac US REIT (KORE - US)	16,500	US$0.435	$10,505.00
24	Manulife REIT (US)	3,000	US$0.555	$2,437.00
25	Prime US REIT (US)	3,000	US$0.525	$2,305.00
26	Veeva Systems	200	US$133.45	$39,065.00
27	Cash			$55,000.00
			TOTAL:	$348,562.00

(1) Portfolio value YTD has reduced from $468,620 to $348,562 (-34.44% against STI index down by 17.6%).

(2) Capital Injected in 2020: $20,500.00.

(3) Total Projected Dividend 2020: $22,000.00

(4) Added some blue chips & REITs.

(5) Added 100 shares of Veeva Systems.

Changing my blog to myinvestmentsystem (Late Post)

I have been continuing to revise my Investment strategy to be the best strategy which suits me the best in the long run.

Investment journey is marathon. It is a process. It is not a destination.

There are so many investment strategies in the market. Some people can sit on with a lot of cash to wait for the market to crash and deploy. Some will do short term trading while others buy undervalued assets to trade.


Since 2020, i have revised my strategy to buy and hold blue chips for indefinite time. Will i only rely on blue chips' yield to compound my portfolio value? The answer is No. I will use the combination of high growth stock with strong economic moat, dividend growth stock and blue chips.


My 8 lessons learned in my 7.5 years of Investment so far:

(1) I started my investment journey in Sep 2012 with growth stocks. In my 7.5 years of investing, i have scored 2 multibagger stocks - Best World: earned me 6x of my invested capital with the holding period of about 3 years, - AEM: earned me 2x of my invested capital with the holding period of about 2 years. - Super growth stocks with high ROE suits my personality.


(2) I used to buy growth stock with large amount of capital against my total portfolio value. I bought 300,000 shares of SingMedical a year ago with an average cost of about $0.39/share.

Total invested value is about $117,000 in a single counter. I thought SingMedical has a very good prospect in term of ROE. However, i was wrong. SingMedical is not a high growth company. The company is very service oriented. It has no competitive moat. Moreover, SingMedical did not declare dividend when i first bought into it. - If the company has no economic moat and does not pay dividend, i should not buy into this kind of companies.


(3) When i first analysed SingMedical, it had a growth plan. The growth plan did not really turn into growth action yet with the revenue and profit growth are very slow/low year to year (less than 10%). - Either growth plan or growth action, we actually can read from their revenue & profit growth rate YoY or QoQ.


(4) Based on "The Little Book That Beats The Market". One of my core portfolio criteria should be super blue chips or blue chips in Singapore which have been existing for more than 10 years. It will consist of blue chips, REITs, and some small caps growth dividend stocks (which paying regular dividends) in Singapore. In the past years, i have wasted a lot of money and time in the market by investing too much cash into a single counter which is not super growth. - Invest into super blue chips or blue chips in Singapore with good track record of multi years (track record of minimum 5 - 10 years).


(5) Capital allocation to a single counter should not exceed 5% for dividend growth stocks & Reits and 10% for super blue chips & high growth stocks since i am not a subject expert of any companies. I can read financial report but i am not able to interpret it correctly according to the company's real situation and i can make hundreds of assumptions to the numbers / management quality / events but i do not know the real situation.


(6) Any dividend cut is not acceptable for consecutive quarters. - Do not invest in any blue chips ore Reits or dividend stocks which has history of cutting dividends. (Except pandemic situation).


(7) If the company is a  super growth with wide economic moat, i will invest about 10% of my total portfolio value. But, will be buying in batches:

1st: 25%

2nd: 25% - drop 5% from my 1st batch

3rd: 20% - drop 5% from my 2nd batch

4th: 15% - drop 5% from my 3rd batch

5th: 15% - drop 5% from my 4th batch

- Buy in batches for high growth company with revenue & profit growth > 30%.
- In my remaining life, i challenge myself to only buy 6 companies of this type. 


(8) I shall reinvest my dividend back into the portfolio if i still have my active income. - Always reinvest back my dividend into the portfolio.

Portfolio Value as per 31 December 2019 (Late Post)

It has been more than 6 months since i last updated my blog.

Tons of things have happened during this period.

I started my Investment journey at the end of 2012 with focusing in small cap (growth stocks) only. Never at once i thought of buying blue chips as their financial reports were definitely out of my understanding and comprehension. But since the mid of this year, i discovered that i need some sort of balancing strategies in my portfolio as i am not comfortable to time/predict the market. Thus, my cash level has always been in the low side. I am comfortable to be in the market all the time. The best is never sell or cash out. Since then, i have been adding some blue chips (super blues) & Reits in my portfolio. So far i have accumulated about 12 of them. I intend to keep adding them as and when i have some fund allocated until they reach about 20. I am also eyeing on some Reits with sustainable dividend yield of above 5% pa. Hopefully i can divest some of my growth stocks when their  valuation have almost reached to their real business value then i am able to allocate this free fund to super blues and/or Reits.

I do believe this strategy is far from perfect. Will keep revise it until it suits me best. Along with my improvement of Investment Knowledge and the increasing of my Portfolio Value, hopefully it will perform better and better!


Wish me all the best and Happy New Year 2020 to all!

No.	Counters	No of Shares	Market Price per Share (SGD)	Total Value (SGD)
1	AEM	25,000	$2.02	$50,500.00
2	Centurion	50,000	$0.445	$22,250.00
3	Comfortdelgro	5,000	$2.38	$11,900.00
4	DBS	800	$25.88	$20,704.00
5	Innotek	120,000	$0.455	$54,600.00
6	Koufu	60,000	$0.77	$46,200.00
7	Mapletree Ind Tr	2,000	$2.60	$5,200.00
8	Mapletree Log Tr	3,200	$1.74	$5,568.00
9	Netlink Nbn Tr	10,000	$0.945	$9,450.00
10	OCBC	1,500	$10.98	$16,470.00
11	Singtel	3,000	$3.37	$10,110.00
12	SGX	600	$8.86	$5,316.00
13	Sia Engineering	2,000	$2.82	$5,640.00
14	SingMedical	250,000	$0.30	$75,000.00
15	ST Engineering	1,200	$3.94	$4,728.00
16	Sunningdale	50,000	$1.33	$66,500.00
17	UOB	400	$26.41	$10,564.00
18	HSBC (Hongkong)	800	HKD60.85 (SG$10.56)	$8,448.00
19	Veeva Systems (NYSE)	100	US$140.66 (SG$189.86)	$18,986.00
20	Cash			$20,486.32
	Total Dividend 2019	$12,590.50
			TOTAL:	$468,620.32

(1) Total Capital added in 2019: $13,010.28.

(2) Total Dividend received in 2019: $12,590.50.

(3) My portfolio has grown from $442,543.50 (as per end December 2018) to $468,620.32.
Portfolio value has gone up by $26,076.82 including capital injected.
Portfolio value has gone up by $13,066.54 or about 2.95% in 2019 (excluding capital injected).

(4) The biggest dragged draw was from SingMedical - down from 40cts to 30cst or about 25%.

(Dragged down by about 5.65% from portfolio value YoY).

(5) Added 10 super blue chips and 2 Reits. 

(6) Bought Koufu.

(7) Bought Veeva Systems, NYSE growth stock which building industry cloud for life sciences - focusing on industry specific cloud applications and the data the professional services as well as the eco-cystem and their partners to put all together in a system that can work.
Interesting company and plan to add more.

(8) Sold Tat Seng Packaging & ANI Pharmaceuticals with some losses.

(9) Reduced AEM, Innotek, & Sunningdale.

(10). Plan to add DBS, UOB, OCBC, ST Engineering, SIA Engineering, Comfort, Singtel, Ascendas Reit, AIMS Ind Reit, and Frasers Log & Ind Trust.

(11) Continue to rebalance portfolio going forward 2020.